Maze Therapeutics (MAZE) Other Non Operating Income (2024 - 2026)

Maze Therapeutics has disclosed Other Non Operating Income across 3 years of filings, most recently posting $2.3 million for Q1 2026.

• Other Non Operating Income for Q1 2026 came in at $2.3 million, down 10.33% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.3 million (up 260.51% YoY), and the FY2024 annual result was -$8.8 million, changed N/A from the prior year.
• Other Non Operating Income came in at $2.3 million for Q1 2026 at Maze Therapeutics, down from $2.6 million in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $2.6 million in Q1 2025 to a low of -$4.8 million in Q1 2024.
• The 3-year median for Other Non Operating Income is -$714000.0 (2024), against an average of -$646166.7.
• Across the five-year window, Other Non Operating Income jumped 154.93% in 2025 and fell 10.33% in 2026, its largest moves.
• Maze Therapeutics' Other Non Operating Income stood at -$1.6 million in 2024, then soared by 259.06% to $2.6 million in 2025, then declined by 10.33% to $2.3 million in 2026.
• The last three Other Non Operating Income figures came in at $2.3 million (Q1 2026), $2.6 million (Q1 2025), and -$1.6 million (Q4 2024), per Business Quant data.